Northside Capital Management LLC Invests $5.90 Million in GE HealthCare Technologies Inc. $GEHC

Key Points

• Northside Capital Management LLC has made a significant investment of approximately $5.90 million in GE HealthCare Technologies Inc., acquiring 79,655 shares during the second quarter.
• In its most recent earnings report, GE HealthCare Technologies posted an EPS of $1.06, surpassing analysts' expectations, and reported a revenue of $5 billion for the quarter.
• The company has announced a quarterly dividend of $0.035, reflecting a 0.2% annual dividend yield with a current payout ratio of just 2.87%.

Northside Capital Management LLC acquired a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 79,655 shares of the company's stock, valued at approximately $5,900,000.

Other institutional investors have also recently made changes to their positions in the company. N.E.W. Advisory Services LLC purchased a new stake in shares of GE HealthCare Technologies during the first quarter worth about $25,000. Bogart Wealth LLC grew its position in shares of GE HealthCare Technologies by 260.0% during the first quarter. Bogart Wealth LLC now owns 342 shares of the company's stock worth $28,000 after purchasing an additional 247 shares in the last quarter. Stonebridge Financial Group LLC grew its position in shares of GE HealthCare Technologies by 165.7% during the first quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock worth $29,000 after purchasing an additional 222 shares in the last quarter. Ameriflex Group Inc. purchased a new stake in shares of GE HealthCare Technologies during the fourth quarter worth about $31,000. Finally, Olde Wealth Management LLC purchased a new stake in shares of GE HealthCare Technologies during the first quarter worth about $35,000. Institutional investors own 82.06% of the company's stock.

GE HealthCare Technologies Price Performance

GEHC opened at $74.60 on Wednesday. The business has a fifty day moving average of $74.54 and a 200 day moving average of $73.03. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85. The stock has a market cap of $34.06 billion, a P/E ratio of 15.29, a PEG ratio of 2.86 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.91 by $0.15. The company had revenue of $5 billion during the quarter, compared to analysts' expectations of $4.96 billion. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.GE HealthCare Technologies's revenue was up 3.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 25th were given a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend was Friday, July 25th. GE HealthCare Technologies's payout ratio is presently 2.87%.

Wall Street Analysts Forecast Growth

GEHC has been the subject of several research analyst reports. BTIG Research reiterated a "buy" rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th. Wall Street Zen cut GE HealthCare Technologies from a "buy" rating to a "hold" rating in a research report on Saturday. Morgan Stanley set a $74.00 target price on GE HealthCare Technologies in a research report on Thursday, September 18th. Zacks Research upgraded GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a research report on Thursday, August 28th. Finally, Citigroup increased their target price on GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a "buy" rating in a research report on Thursday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat.com, GE HealthCare Technologies has an average rating of "Moderate Buy" and an average price target of $88.40.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.